SPY313.47+2.95 0.95%
DIA259.47+2.16 0.84%
IXIC10,250.95+96.32 0.95%

Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $95

Morgan Stanley maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $90 to $95.

Benzinga · -

Morgan Stanley maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $90 to $95.